Divi’s Laboratories Ltd. (DIVISLAB): Divi’s Laboratories Share Price Hits Fresh 52-Week High at Rs 9,500
- September 8, 2026
- Posted by: Harsh Piplani
- Category: News
Divi’s Laboratories Share Price is trading at Rs 9,500 after rising 2.1% from the previous close of Rs 9,305, and the stock has touched a fresh 52-week high of Rs 9,529.80. Divi’s Laboratories Ltd. (DIVISLAB) now has a market capitalisation of Rs 2,41,576.41 crore, putting today’s move in clear focus for Divi’s Laboratories Share Price Today and Divi’s Laboratories Stock News. The latest Univest figures confirm the price event, but they do not establish a company-specific catalyst. What stands out is the gap between the current price and the prior yearly high, along with the way the stock is being tracked in Indian Stock Market and Share Market Today searches.
As of 08 September 2026 at 11:22 AM IST, Divi’s Laboratories Share Price has moved to a yearly high while trading between Rs 9,256 and Rs 9,529.80 so far today. The stock opened at Rs 9,382.65 and is last traded near the upper end of that range. For readers following Divi’s Laboratories Share Price Live, the move is relevant because it combines a fresh 52-week high with a large market capitalisation and a valuation profile that remains a key part of Divi’s Laboratories Stock Analysis on Univest.
Divi’s Laboratories Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 9,500 |
| Previous Close | Rs 9,305 |
| Today's Move | +Rs 195 (+2.1%) |
| Open | Rs 9,382.65 |
| High | Rs 9,529.8 |
| Low | Rs 9,256 |
| Turnover | Rs 55.54 crore |
| Market Capitalisation | Rs 2,41,576.41 crore |
Divi's Laboratories Ltd. (DIVISLAB) traded at Rs 9,500 versus the previous close of Rs 9,305, a rise of 2.1%. The stock opened at Rs 9,382.65, reached a high of Rs 9,529.8 and touched a low of Rs 9,256.
Divi’s Laboratories Share Price Today reflects a firm intraday move: the stock is trading at Rs 9,500 after a gain of Rs 195 over the previous close. The day opened at Rs 9,382.65, slipped to Rs 9,256, and then touched Rs 9,529.80, which is also the fresh 52-week high. That means the stock has moved Rs 24.80 above the earlier yearly high of Rs 9,505 only when considering the current high-versus-previous-high spread, while the current price remains just below the day’s peak.
Turnover stands at Rs 55.54 crore, which is a factual trading-value measure and not a comment on participation or conviction. The price action places Divi’s Laboratories Share Price in the list of 52 Week High Stocks and keeps it relevant for Stocks in News, Top Gainers Today and Market Movers screens. The move is being discussed because it combines a new yearly high with an intraday range that shows the stock has already tested both sides of the day’s band.
Divi's Laboratories Ltd. (DIVISLAB) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 2,41,576.41 crore |
| P/E Ratio | 84.45x |
| P/B Ratio | 13.99x |
| ROE | 16.19% |
| ROCE | 21.51% |
| EPS | Rs 110.18 |
| Book Value Per Share | Rs 665.36 |
| Dividend Yield | 0.32% |
Divi's Laboratories Ltd. (DIVISLAB) fundamental metrics show P/E 84.45x, P/B 13.99x, ROE 16.19%, ROCE 21.51%. These figures provide context only and are not a buy or sell signal.
Divi’s Laboratories Ltd. has a market capitalisation of Rs 241576.41 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 84.45x, P/B at 13.99x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 16.19% and ROCE of 21.51%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 110.18, book value per share of Rs 665.36, dividend yield of 0.32%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 32.47x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 84.45x |
| Benchmark Median P/E | 32.47x |
| Benchmark Average P/E | 48.79x |
| Benchmark P/E Range | 3.35x to 654.07x |
| Company P/B Ratio | 13.99x |
| Benchmark Median P/B | 2.97x |
| Company ROE | 16.19% |
| Benchmark Median ROE | 11.81% |
| Company ROCE | 21.51% |
| Benchmark Median ROCE | 13.68% |
| Company Market Capitalisation | Rs 2,41,576.41 crore |
| Benchmark Median Market Cap | Rs 687.66 crore |
Divi's Laboratories Ltd. (DIVISLAB) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 84.45x, which is above the benchmark median of 32.47x, a difference of +160.09%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Divi's Laboratories Ltd. (DIVISLAB) has a ROE of 16.19%, which is above the benchmark median of 11.81%, a difference of +37.09%. Divi's Laboratories Ltd. (DIVISLAB) has a ROCE of 21.51%, which is above the benchmark median of 13.68%, a difference of +57.24%.
Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,84,478.41 | 85.68 | 20.82 | 26.76 | 19.27 |
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,55,633.71 | 37.69 | 5.27 | 14.85 | 19.11 |
| Cipla Ltd. | CIPLA | 1,11,888.39 | 33.46 | 3.21 | 11.83 | 16 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,11,820.18 | 25.53 | 4.27 | 19.69 | 21.39 |
| Laurus Labs Ltd. | LAURUSLABS | 99,417.45 | 92.32 | 17.9 | 18.31 | 18.2 |
Divi's Laboratories Ltd. (DIVISLAB) has a P/E ratio of 84.45x compared with the displayed peer median of 37.69x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 16.19% compares with a peer median of 18.31% across the companies shown in the table. ROCE stood at 21.51% versus the displayed peer median of 19.11%, providing a capital-efficiency comparison. Divi's Laboratories Ltd. (DIVISLAB) has a market capitalisation of Rs 2,41,576.41 crore. Among the 5 peers shown, 1 has a larger market capitalisation.
Why Investors Are Watching Divi’s Laboratories
- Divi’s Laboratories Share Price touched Rs 9,529.80, which is a fresh 52-week high and the key price event today.
- Divi’s Laboratories Share Price Today is at Rs 9,500, after a rise of Rs 195 from the previous close of Rs 9,305.
- The company’s market capitalisation is Rs 2,41,576.41 crore, which places Divi’s Laboratories Share Price in a very large company size band.
- P/E is 84.45 and P/B is 13.99, both above the sector medians in the same-industry benchmark.
- ROE of 16.19% and ROCE of 21.51% are above the same-industry medians and remain part of Divi’s Laboratories Fundamental Analysis.
About Divi’s Laboratories
Divi’s Laboratories Ltd. operates in the Healthcare sector and the Pharmaceuticals & Drugs industry. In this market context, Divi’s Laboratories Share Price is often discussed alongside the company’s earnings metrics, book value, dividend yield and revenue trend. The latest company financials show revenue movement across recent quarters, while the business continues to be tracked through Divi’s Laboratories Financial Results, Divi’s Laboratories Latest News and Divi’s Laboratories Stock Performance updates on Univest.
Frequently Asked Questions
Why is Divi's Laboratories Share Price in focus today?
Ans. Divi's Laboratories Share Price is in focus because it touched a fresh 52-week high of Rs 9,529.80 and was trading at Rs 9,500, up 2.1% from the previous close.
What is the current Divi's Laboratories Share Price?
Ans. Divi's Laboratories Share Price is trading at Rs 9,500. The previous close was Rs 9,305, so the stock is up Rs 195 for the day as of 08 September 2026 at 11:22 AM IST.
What is the fresh 52-week high for Divi's Laboratories Share Price?
Ans. The fresh 52-week high for Divi's Laboratories Share Price is Rs 9,529.80. That level also matches the day’s high, which places the stock at a yearly peak during the current trading session.
How large is Divi's Laboratories by market capitalisation?
Ans. Divi's Laboratories has a market capitalisation of Rs 2,41,576.41 crore. That makes size a major part of Divi's Laboratories Share Price analysis, alongside valuation, earnings and sector comparison.
What do the valuation ratios suggest for Divi's Laboratories Share Price?
Ans. Divi's Laboratories Share Price carries a P/E of 84.45 and a P/B of 13.99. Both are above the same-industry benchmark medians, so valuation remains an important part of the current stock discussion.
How do ROE and ROCE compare for Divi's Laboratories?
Ans. Divi's Laboratories reports ROE of 16.19% and ROCE of 21.51%. Both are above the same-industry medians, which adds useful context to Divi's Laboratories Fundamental Analysis and Share Price interpretation.
What are the EPS, book value and dividend yield for Divi's Laboratories Share Price?
Ans. EPS is Rs 110.18, book value per share is Rs 665.36 and dividend yield is 0.32%. These three figures help readers assess earnings, accounting value and historical payout context.
Which peers are useful for comparing Divi's Laboratories Share Price?
Ans. Useful peers include Torrent Pharmaceuticals, Sun Pharmaceutical Industries, Cipla, Zydus Lifesciences and Laurus Labs. Their valuation and profitability metrics help place Divi's Laboratories Share Price in a broader pharmaceutical comparison.
Track Divi’s Laboratories Share Price on Univest
Use Divi's Laboratories Ltd. (DIVISLAB) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.
Track Divi’s Laboratories Share Price on Univest for live price updates, market cap, financial ratios, 52-week levels, company news, sector context and peer comparison. Univest also helps readers follow Divi’s Laboratories Share Price Live, Divi’s Laboratories Fundamental Analysis and Divi’s Laboratories Share Price Update in one place.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
